» Articles » PMID: 33029670

Opioid-Mediated HIV-1 Immunopathogenesis

Overview
Date 2020 Oct 8
PMID 33029670
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the ability of combination antiretroviral therapy to dramatically suppress viremia, the brain continues to be a reservoir of HIV-1 low-level replication. Adding further complexity to this is the comorbidity of drug abuse with HIV-1 associated neurocognitive disorders and neuroHIV. Among several abused drugs, the use of opiates is highly prevalent in HIV-1 infected individuals, both as an abused drug as well as for pain management. Opioids and their receptors have attained notable attention owing to their ability to modulate immune functions, in turn, impacting disease progression. Various cell culture, animal and human studies have implicated the role of opioids and their receptors in modulating viral replication and virus-mediated pathology both positively and negatively. Further, the combinatorial effects of HIV-1/HIV-1 proteins and morphine have demonstrated activation of inflammatory signaling in the host system. Herein, we summarized the current knowledge on the role of opioids on peripheral immunopathogenesis, viral immunopathogenesis, epigenetic profiles of the host and viral genome, neuropathogenesis of SIV/SHIV-infected non-human primates, blood-brain-barrier, HIV-1 viral latency, and viral rebound. Overall, this review provides recent insights into the role of opioids in HIV-1 immunopathogenesis. Graphical abstract.

Citing Articles

Structural and Functional Dysregulation of the Brain Endothelium in HIV Infection and Substance Abuse.

Annadurai N, Kanmogne G Cells. 2024; 13(17.

PMID: 39272987 PMC: 11393916. DOI: 10.3390/cells13171415.


Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications.

Xu S, Li H, Ai Z, Guo R, Cheng H, Wang Y PLoS Pathog. 2024; 20(8):e1012397.

PMID: 39116040 PMC: 11309435. DOI: 10.1371/journal.ppat.1012397.


The Impact of Drugs and Substance Abuse on Viral Pathogenesis-A South African Perspective.

Ratshisusu L, Simani O, Blackard J, Selabe S Viruses. 2024; 16(6).

PMID: 38932263 PMC: 11209167. DOI: 10.3390/v16060971.


A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation.

Thirugnanam S, Rout N Curr Issues Mol Biol. 2024; 46(5):4768-4786.

PMID: 38785555 PMC: 11119826. DOI: 10.3390/cimb46050287.


Role of Dysregulated Autophagy in HIV Tat, Cocaine, and cART Mediated NLRP3 Activation in Microglia.

Singh S, Thangaraj A, Chivero E, Guo M, Periyasamy P, Buch S J Neuroimmune Pharmacol. 2023; 18(3):327-347.

PMID: 37148425 PMC: 10729649. DOI: 10.1007/s11481-023-10063-0.


References
1.
Wang J, Barke R, Charboneau R, Schwendener R, Roy S . Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J Immunol. 2008; 180(5):3594-600. DOI: 10.4049/jimmunol.180.5.3594. View

2.
Kovalevich J, Langford D . Neuronal toxicity in HIV CNS disease. Future Virol. 2013; 7(7):687-698. PMC: 3632417. DOI: 10.2217/fvl.12.57. View

3.
Wang X, Ye L, Hou W, Zhou Y, Wang Y, Metzger D . Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood. 2008; 113(3):671-4. PMC: 2628373. DOI: 10.1182/blood-2008-09-175000. View

4.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

5.
Chang S, Connaghan K . Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins. J Neuroimmune Pharmacol. 2011; 7(2):332-40. DOI: 10.1007/s11481-011-9324-1. View